Status:
UNKNOWN
Anatomic Stenosis Severity as a Prognostic Marker in Patients With Low-Flow Low-Gradient Aortic Stenosis Undergoing TAVI
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions:
Low-Flow, Low-Gradient Aortic Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
The ATLAS TAVI Registry is a retrospective, investigator-initiated, multicenter registry including patients, who underwent Transcatheter Aortic Valve Implantation (TAVI) for classical or paradoxical l...
Detailed Description
Aortic valve calcification (AVC) as assessed by MSCT is highly correlated with aortic stenosis (AS) severity and, thus, has become an important tool for diagnosing severe AS, especially in patients wi...
Eligibility Criteria
Inclusion
- age ≥18 years
- patient gave written informed consent for data acquisition and transfer
- for LFLG AS: -- available non-contrast MSCT data on aortic valve calcification (AVC, Agatston Units)
Exclusion
- \- LFLG AS without non-contrast MSCT data on AVC
Key Trial Info
Start Date :
April 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04914481
Start Date
April 1 2021
End Date
December 31 2025
Last Update
June 4 2021
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal Heart Institute
Montreal, Canada
2
Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval
Québec, Canada
3
Odense University Hospital
Odense, Denmark
4
CHU de Lille
Lille, France